Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/0885066620940259 http://scihub22266oqcxt.onion/10.1177/0885066620940259 32666875!7391476!32666875     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Intensive+Care+Med 2020 ; 35 (9): 827-835 Nephropedia Template TP {{tp|p=32666875|t=2020. Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients |pdf=|usr=}}{{32666875}} gab.com Text Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients JO: J Intensive Care Med http://www.kidney.de/pget.php?&tw=1&pmid=32666875 #FOAvip In the 5 months since initial reports of COVID-19 came to light, the death toll due to SARS-CoV-2 has rapidly increased. The morbidity and mortality of the infection varies based upon patient age, comorbid conditions, viral load, and the availability of effective treatments. Findings from limited autopsies, clinical observations, and laboratory data suggest that high cytokine levels and a procoagulant state can precipitate acute respiratory distress syndrome and multi-organ dysfunction syndrome in critically ill patients. To complicate matters, comorbidities may affect the response to medical treatments currently in use, all of which are still in trial phase. Therapeutic plasma exchange (TPE) merits consideration in the treatment of critically ill COVID-19 patients and is an avenue for clinical trials to pursue. If efficacious, faster recovery of patients may lead to shorter intensive care unit stays and less time on mechanical ventilation. Herein, we briefly discuss some of the various approaches currently being investigated for the treatment of SARS-CoV-2 with a focus on potential benefits of TPE for selected critically ill patients. Twit Text FOAVip Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients ????J Intensive Care Med http://www.kidney.de/pget.php?&tw=1&pmid=32666875 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32666875 #FOAvip English Wikipedia <ref>{{Cite pmid|32666875}}</ref> Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients #MMPMID32666875 Tabibi S; Tabibi T; Conic RRZ; Banisaeed N; Streiff MB J Intensive Care Med 2020[Sep]; 35 (9): 827-835 PMID32666875show ga In the 5 months since initial reports of COVID-19 came to light, the death toll due to SARS-CoV-2 has rapidly increased. The morbidity and mortality of the infection varies based upon patient age, comorbid conditions, viral load, and the availability of effective treatments. Findings from limited autopsies, clinical observations, and laboratory data suggest that high cytokine levels and a procoagulant state can precipitate acute respiratory distress syndrome and multi-organ dysfunction syndrome in critically ill patients. To complicate matters, comorbidities may affect the response to medical treatments currently in use, all of which are still in trial phase. Therapeutic plasma exchange (TPE) merits consideration in the treatment of critically ill COVID-19 patients and is an avenue for clinical trials to pursue. If efficacious, faster recovery of patients may lead to shorter intensive care unit stays and less time on mechanical ventilation. Herein, we briefly discuss some of the various approaches currently being investigated for the treatment of SARS-CoV-2 with a focus on potential benefits of TPE for selected critically ill patients. |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*immunology/*therapy[MESH] |Critical Illness/*therapy[MESH] |Humans[MESH] |Pandemics[MESH] |Plasma Exchange/*methods[MESH] |Plasma/*immunology[MESH] |Pneumonia, Viral/*immunology/*therapy[MESH]Therapeutic Plasma Exchange: A potential Management Strategy for Criti(epmc).pdf DeepDyve Pubget Overpricing